Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1078 (INR) • At close May 16, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 0368.20504.9887,535575.767-4,869.49648.028-4,123.004665.701-5,257.862445.638-2,293.932173.378-1,877.7671.822-876.308121.453-443.624116.953-198.405109.03
Short Term Investments 06,361.607,738.95506,562.69,738.984,224.2798,246.0083,457.30310,515.7244,812.2244,587.8642,120.5543,755.521,805.9381,752.616754.883887.248306.761396.8170.638
Cash and Short Term Investments 6,558.86,729.88,211.2678,243.9437,5357,138.3674,869.494,872.3074,123.0044,123.0045,257.8625,257.8622,293.9322,293.9321,877.761,877.76876.308876.336443.624423.714198.405179.668
Net Receivables 0001,336.5921,2641,368.98701,109.39301,111.54502,363.72301,639.02401,023.82101,055.43401,171.95800
Inventory 02,154.802,311.9572,5322,714.62903,128.10503,183.07902,834.17302,646.22702,010.80401,974.88101,748.72301,570.982
Other Current Assets -6,558.82,791.90758.1350470.2540857.9210807.3260657.5680719.1630619.0790883.022064.334034.439
Total Current Assets 011,676.58,211.26712,631.86311,33111,690.6874,869.4910,110.4584,123.0049,224.9545,257.86211,279.322,293.9327,298.3461,877.765,647.852876.3084,789.645443.6243,916.467198.4053,897.342
Non-Current Assets:
Property, Plant & Equipment, Net 08,927.607,867.767,8277,612.45507,662.24906,948.33705,619.51305,534.105,348.89605,040.97304,556.5303,792.808
Goodwill 02,137.60602.58360300602.58300000000000000
Intangible Assets 0577.80619.25717620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Goodwill and Intangible Assets 02,715.40619.257620620.2110621.9020623.053022.364024.35025.904026.018027.96026.851
Long Term Investments 0-4,941.401,399.6140-5,323.45101,170.96601,170.96601,170.96603,658.81401,853.93602,557.70202,815.2790-26.191
Tax Assets 073.8044.76106,562.872059.344059.8950203.711052.02601,808.1420755.5030000
Other Non-Current Assets 06,603.7-8,211.267-22.3980134.96-4,869.4932.519-4,123.00432.952-5,257.862-0.001-2,293.93257.582-1,877.7659.921-876.30813.633-443.624411.869-198.405139.353
Total Non-Current Assets 013,379.1-8,211.2679,909.0029,2489,507.047-4,869.499,546.98-4,123.0048,835.203-5,257.8627,016.553-2,293.9329,326.872-1,877.769,096.799-876.3088,393.829-443.6247,811.638-198.4053,932.821
Total Assets 025,055.6022,540.86520,57921,197.734019,657.438018,060.157018,295.873016,625.218014,744.651013,183.474011,728.10507,830.163
Liabilities & Equity:
Current Liabilities:
Account Payables 0652.80423.574420425.9390487.7180855.55901,059.0050982.1480829.3130802.9160710.5570535.749
Short Term Debt 0880437.6080499.190650.7680707.4030682.240945.4301,067.0580976.9340944.4210827.936
Tax Payables 0128.20003.98502.9390130.752036.422012.721000135.807052.53601.096
Deferred Revenue 0006.8870149.5750255.720423.5060340.7040292.350278.5450358.7260309.6530159.691
Other Current Liabilities 01,512.40200.888045.0960438.156047.6560287.271057.1750301.0370-109.8010284.1860211.306
Total Current Liabilities 02,381.401,068.9574201,123.78501,587.65802,164.87602,102.9402,289.82402,197.4802,164.58202,003.71501,576.087
Non-Current Liabilities:
Long Term Debt 0306.60212.35734517.356052.640207.3930289.0330361.340363.2990559.8440917.64400
Deferred Revenue Non-Current 0000000128.5930296.0780373.3490417.2540000083.14600
Deferred Tax Liabilities Non-Current 0859.30647.9120619.0610582.3460563.240543.1510332.4840309.3290276.3720275.9720291.717
Other Non-Current Liabilities -20,284.21,224.1-20,506.635752.915083.4940665.297094.0920632.096066.460375.789083.14600.001059.453
Total Non-Current Liabilities -20,284.22,390-20,506.635965.272345719.9110717.9370864.7250921.1290760.2840739.0880919.36201,276.7630351.17
Total Liabilities -20,284.24,771.4-20,506.6352,034.2297651,843.69602,305.59503,029.60103,024.06903,050.10802,936.56803,083.94403,280.47801,927.257
Equity:
Preferred Stock 0000000000000000000000
Common Stock 0254.60254.56519,814254.5650254.5650254.5650254.5650254.5650254.5650254.5650127.2820127.282
Retained Earnings 00017,651.1800014,651.60600012,727.0860009,364.9260006,154.44303,909.835
Accumulated Other Comprehensive Income/Loss 19,783.4020,506.6351,505.152019,099.47317,351.8431,349.93415,030.55614,775.99115,271.8041,194.41413,575.1113,320.54511,808.0831,350.30310,099.539,844.9658,447.627150.1145,902.9060
Other Total Stockholders Equity 500.819,528.801,095.7380001,095.7380001,095.7380001,095.7380001,223.02101,865.788
Total Shareholders Equity 20,284.219,783.420,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Equity 20,284.220,284.220,506.63520,506.63519,81419,354.03817,351.84317,351.84315,030.55615,030.55615,271.80415,271.80313,575.1113,575.1111,808.08311,808.08310,099.5310,099.538,447.6278,447.6275,902.9065,902.905
Total Liabilities & Shareholders Equity 025,055.6022,540.86520,57921,197.73417,351.84319,657.43815,030.55618,060.15715,271.80418,295.87213,575.1116,625.21811,808.08314,744.65110,099.5313,183.4748,447.62711,728.1055,902.9067,830.162